|
|
|
|
| LEADER |
00000nam a2200000Ia 4500 |
| 001 |
b1913308 |
| 005 |
20240627102819.0 |
| 006 |
m d |
| 007 |
cr cn| |
| 008 |
080715t20082008njua sb 001 0 eng d |
| 020 |
|
|
|a 9781597451697
|
| 020 |
|
|
|a 159745169X
|
| 035 |
|
|
|a (OCoLC)233972860
|
| 035 |
|
|
|a (OCoLC)233972860
|
| 037 |
|
|
|a 978-1-58829-858-4
|b Springer
|n http://www.springerlink.com
|
| 040 |
|
|
|a GW5XE
|c GW5XE
|d UtOrBLW
|
| 049 |
|
|
|a STAM
|
| 245 |
0 |
0 |
|a Cancer proteomics :
|b from bench to bedside /
|c edited by Sayed S. Daoud.
|
| 264 |
|
1 |
|a Totowa, N.J. :
|b Humana Press,
|c [2008]
|
| 264 |
|
4 |
|c ©2008
|
| 300 |
|
|
|a xii, 264 pages :
|b illustrations (some color) ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Cancer drug discovery and development
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Proteomics technologies -- Cell signaling proteomics -- Tumor proteomics -- Bioinformatics and regulatory aspects of proteomics.
|
| 533 |
|
|
|a Electronic reproduction.
|b New York :
|c Springer,
|d 2008.
|n Mode of access: World Wide Web.
|n System requirements: Web browser.
|n Title from title screen (viewed on June 27, 2008).
|n Access may be restricted to users at subscribing institutions.
|
| 650 |
1 |
2 |
|a Neoplasms.
|
| 650 |
1 |
2 |
|a Proteomics
|x methods.
|
| 650 |
2 |
2 |
|a Antineoplastic Agents.
|
| 650 |
2 |
2 |
|a Tumor Markers, Biological.
|
| 650 |
|
0 |
|a Proteomics
|x Methodology.
|
| 650 |
|
0 |
|a Antineoplastic agents
|x Development.
|0 http://id.loc.gov/authorities/subjects/sh97008449
|
| 650 |
|
0 |
|a Cancer
|x Molecular aspects.
|0 http://id.loc.gov/authorities/subjects/sh89006610
|
| 650 |
|
7 |
|a Proteomics.
|2 fast
|0 (OCoLC)fst01079785
|
| 650 |
|
7 |
|a Methodology.
|2 fast
|0 (OCoLC)fst01018722
|
| 650 |
|
7 |
|a Antineoplastic agents
|x Development.
|2 fast
|0 (OCoLC)fst00810599
|
| 650 |
|
7 |
|a Antineoplastic agents.
|2 fast
|0 (OCoLC)fst00810595
|
| 650 |
|
7 |
|a Cancer
|x Molecular aspects.
|2 fast
|0 (OCoLC)fst00845397
|
| 650 |
|
7 |
|a Cancer.
|2 fast
|0 (OCoLC)fst00845317
|
| 700 |
1 |
|
|a Daoud, Sayed S.
|0 http://id.loc.gov/authorities/names/no2008027311
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|0 http://id.loc.gov/authorities/names/no2005046756
|
| 740 |
0 |
|
|a Biomedical and life sciences ebook collection.
|
| 776 |
1 |
|
|c Original
|z 9781588298584
|z 1588298582
|z 9781597451697
|z 159745169X
|w (DLC) 2007938391
|w (OCoLC)166627310
|
| 830 |
|
0 |
|a Cancer drug discovery and development.
|0 http://id.loc.gov/authorities/names/n88538383
|
| 856 |
4 |
0 |
|3 SpringerLink
|u https://login.libproxy.scu.edu/login?url=https://dx.doi.org/10.1007/978-1-59745-169-7
|z Connect to this ebook
|t 0
|
| 907 |
|
|
|a .b1913308x
|b 240629
|c 090818
|
| 918 |
|
|
|a .bckstg
|b 2016-12-01
|
| 998 |
|
|
|a uww
|b 090818
|c m
|d z
|e l
|f eng
|g nju
|h 0
|
| 999 |
f |
f |
|i a78be329-104e-5135-883f-dd4ed3ce850b
|s 9c4bec18-cf3e-53d9-9488-03e9e99e5d60
|t 0
|